Original Research
Published on 22 Nov 2024
Machine learning based anoikis signature predicts personalized treatment strategy of breast cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1491508
Type at least 3 characters
6,645 articles
Articles
Review
Published on 22 Nov 2024
Beclin-1: a therapeutic target at the intersection of autophagy, immunotherapy, and cancer treatment
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1506426
Original Research
Published on 22 Nov 2024
Prediction of acute myeloid leukemia prognosis based on autophagy features and characterization of its immune microenvironment
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1489171
- 155 views
Mini Review
Published on 22 Nov 2024
The role of ACER2 in intestinal sphingolipid metabolism and gastrointestinal cancers
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1511283
Original Research
Published on 22 Nov 2024
Effect of hypoxia-induced mIL15 expression on expansion and memory progenitor stem-like TILs in vitro
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1450245
- 107 views
Review
Published on 22 Nov 2024
Modulation of gut microbiota by probiotics to improve the efficacy of immunotherapy in hepatocellular carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1504948
- 100 views
Case Report
Published on 22 Nov 2024
Clinical characteristics and biomarkers of severe immune checkpoint inhibitor-related pneumonitis triggered by immunotherapy followed by radiation: a case report
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1454114
Review
Published on 22 Nov 2024
Harnessing antibody-mediated recognition of the intracellular proteome with T cell receptor-like specificity
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1486721
Original Research
Published on 22 Nov 2024
Acute remote ischemic conditioning enhances (CD3+)- but not (FoxP3+)-T-cell invasion in the tumor center and increases IL 17 and TNF-alpha expression in a murine melanoma model
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1501885
Original Research
Accepted on 21 Nov 2024
Development of a recombinant human IgG1 monoclonal antibody against the TRBV5-1 segment of the T cell receptor for the treatment of mature T cell neoplasms
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1520103
Original Research
Accepted on 21 Nov 2024
TLS and immune cell profiling: Immunomodulatory effects of immunochemotherapy on tumour microenvironment in resectable stage III NSCLC
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1499731
Original Research
Accepted on 21 Nov 2024
m6A Methylation Profiling as a Prognostic Marker in Nasopharyngeal Carcinoma: Insights from MeRIP-Seq and RNA-Seq
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1492648
Original Research
Accepted on 21 Nov 2024
Innovative Strategies to Optimise Colorectal Cancer Immunotherapy through Molecular Mechanism Insights
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1509658
Original Research
Accepted on 21 Nov 2024
Colorimetric Aptasensor Coupled with a Deep-learning Powered Smartphone app for Programmed Death Ligand-1 Expressing Extracellular Vesicles
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1479403
Opinion
Accepted on 21 Nov 2024
Exploring the Synergy Between Tumor Microenvironment Modulation and STING Agonists in Cancer Immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1488345
Original Research
Accepted on 21 Nov 2024
Decoding the Prognostic Landscape of LUAD: The Interplay Between N6-methyladenosine Modification and Immune Microenvironment
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1514497